Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116103254B reveals stable enzyme mutants for UDCA. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110577974B reveals a green enzymatic route for high-purity chiral tetrahydropyridines, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel enzymatic route for Finerenone intermediates reduces heavy metal risk and cost significantly. Ideal for reliable pharmaceutical intermediate supplier partnerships seeking green chemistry.
Patent CN105461606A reveals enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de purity and scalable green manufacturing for Hepatitis C drug supply chains.
Patent CN104263776A reveals high-yield biocatalytic route for chiral pyridine ethanol offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN106978452B reveals ionic liquid modified lipase method for kojic acid ester. Enhances yield and stability for food additive manufacturing supply chains.
Patent CN113930415A details a novel enzymatic route for antifungal intermediates, offering high stereoselectivity and simplified purification for scalable manufacturing.
Patent CN102899367B details a hybrid bio-chemical synthesis for high-purity Tenofovir. This method offers significant cost reduction and scalable manufacturing for API intermediates.
Patent CN113201516A details a novel P-nitrobenzyl esterase mutant for solvent-free L-menthol production, offering superior stereoselectivity and cost-effective manufacturing.
Patent CN104726513B details high-yield enzymatic Levodopa production. Offers cost reduction in pharmaceutical manufacturing and scalable supply chain solutions for global buyers.
Patent CN104327039A reveals enzymatic synthesis for rosuvastatin intermediate offering milder conditions and reduced solvent consumption for supply chain optimization.
Patent CN120005840A reveals TgDH enzyme for high-purity chiral ketene synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Advanced biocatalytic synthesis of betulinic acid using ionic liquids. Enhances yield and supply chain reliability for pharmaceutical intermediates.
Patent CN101892273B reveals immobilized lipase Lipozyme TLIM enables green, high-yield asymmetric Michael addition, offering cost reduction in pharmaceutical intermediate manufacturing.
Discover the enzymatic synthesis of 3 beta 7 beta dihydroxy 5 alpha H UDCA isomer. A cost-effective, high-purity pharmaceutical intermediate solution.
Patent CN113264868B reveals an improved synthesis of 1-benzyl-3-piperidinol with superior stereoselectivity. Discover cost-effective manufacturing strategies for Benidipine intermediates.
Patent CN111778297B details a high-yield enzymatic route for chiral piperidine intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN108504701A details enzymatic synthesis of metolachlor intermediate offering high purity and scalable production for reliable agrochemical intermediate supply chains.
Patent CN109609474B reveals a high-efficiency amino acid dehydrogenase mutant for L-glufosinate production, offering significant cost reduction and supply chain reliability.
Novel enzymatic route for Dapoxetine intermediate ensures high purity and scalable production. Offers significant cost reduction and supply chain reliability for global API manufacturers.